注射用头孢哌酮钠舒巴坦钠临床应用效果及不良反应发生情况研究(1)
摘 要：目的 从细菌学、不良反应评价注射用头孢哌酮钠舒巴坦钠应用价值，分析疗效影响因素，为医院遴选抗菌药物、合理用药提供参考。方法 2017年1月～12月我院共使用注射用头孢哌哃钠舒巴坦钠治疗重症感染患者254例，将痊愈对象纳入痊愈组，其余纳入对照组，收集资料，进行因素分析。描述性分析不良反应发生情况。结果 感染控制率94.49%(240/254)，微生物清除率87.01%(221/254)，未见细菌交替、再感染情况。痊愈率49.21%(125/254)、有效率47.24%(120/254)、无效率3.54%(9/254)。多因素Logistic回归分析：热程[OR=1.016，95%CI(0.985～1.106]、PLT[OR=0.924，95%CI(0.542～0.947)]、抗生素耐药[OR=13.426，95%CI(1.566～44.115)]、混合感染[OR=1.126，95%CI(1.247～1.547]、精神萎靡不振[OR=1.257，95%CI(1.468～3.918)]、有并發症[OR=1.225，95%CI(1.114～2.359)]成为独立影响因素(P<0.05)。未见注射用头孢哌酮钠舒巴坦有关严重不良反应，出现1例菌群失调。结论 注射用头孢哌酮钠舒巴坦钠不良反应发生率低，单中心应用于重症感染疗效肯定，但疗效容易受到多种因素影响，需要加强耐药性、病原学监测，提高经验性用药水平。
, 百拇医药
关键词：头孢哌酮钠舒巴坦钠；重症感染；不良反应
中图分类号：R978.1 文献标识码：A DOI：10.3969/j.issn.1006-1959.2018.12.040
文章编号：1006-1959(2018)12-0131-03
Abstract：Objective To evaluate the value of cefoperazone sodium and sulbactam sodium for injection from bacteriological and adverse reactions，analyze the influencing factors，and provide reference for hospital selection of antimicrobial drugs and rational drug use.Methods A total of 254 patients with severe infections were treated with cefoperazone sodium and sulbactam sodium for injection from January to December 2017.The recovery targets were included in the recovery group and the rest were included in the control group.Data were collected and factor analysis was performed.Descriptive analysis of the occurrence of adverse reactions.Results The infection control rate was 94.49%(240/254)and the microbial clearance rate was 87.01%(221/254).There was no bacterial alternation and reinfection.The cure rate was 49.21%(125/254)，the effective rate was 47.24%(120/254)，and the inefficiency was 3.54%(9/254). Multivariate logistic regression analysis： heat history[OR=1.016，95%CI(0.985～1.106]，PLT[OR=0.924，95% CI(0.542～0.947)]，antibiotic resistance[OR=13.426，95% CI(1.566～44.115)]，mixed infection[OR=1.126，95%CI(1.247～1.547]，lack of spirit[OR=1.257，95%CI(1.468～3.918)]，with complications[OR=1.225，95%CI(1.114～2.359)became an independent influencing factor(P<0.05).There was no serious adverse reaction related to cefoperazone sodium sulbactam for injection，and 1 case of dysbacteriosis occurred.Conclusion The incidence of adverse reactions of cefoperazone sodium and sulbactam sodium for injection is low.Single-center application of severe infection is affirmative，but the efficacy is easily affected by many factors.It is necessary to strengthen drug resistance，pathogen monitoring，and improve the level of empirical drug use.
Key words：Cefoperazone sodium sulbactam sodium；Severe infection；Adverse reactions, 百拇医药(沈孟杰)
, 百拇医药
关键词：头孢哌酮钠舒巴坦钠；重症感染；不良反应
中图分类号：R978.1 文献标识码：A DOI：10.3969/j.issn.1006-1959.2018.12.040
文章编号：1006-1959(2018)12-0131-03
Abstract：Objective To evaluate the value of cefoperazone sodium and sulbactam sodium for injection from bacteriological and adverse reactions，analyze the influencing factors，and provide reference for hospital selection of antimicrobial drugs and rational drug use.Methods A total of 254 patients with severe infections were treated with cefoperazone sodium and sulbactam sodium for injection from January to December 2017.The recovery targets were included in the recovery group and the rest were included in the control group.Data were collected and factor analysis was performed.Descriptive analysis of the occurrence of adverse reactions.Results The infection control rate was 94.49%(240/254)and the microbial clearance rate was 87.01%(221/254).There was no bacterial alternation and reinfection.The cure rate was 49.21%(125/254)，the effective rate was 47.24%(120/254)，and the inefficiency was 3.54%(9/254). Multivariate logistic regression analysis： heat history[OR=1.016，95%CI(0.985～1.106]，PLT[OR=0.924，95% CI(0.542～0.947)]，antibiotic resistance[OR=13.426，95% CI(1.566～44.115)]，mixed infection[OR=1.126，95%CI(1.247～1.547]，lack of spirit[OR=1.257，95%CI(1.468～3.918)]，with complications[OR=1.225，95%CI(1.114～2.359)became an independent influencing factor(P<0.05).There was no serious adverse reaction related to cefoperazone sodium sulbactam for injection，and 1 case of dysbacteriosis occurred.Conclusion The incidence of adverse reactions of cefoperazone sodium and sulbactam sodium for injection is low.Single-center application of severe infection is affirmative，but the efficacy is easily affected by many factors.It is necessary to strengthen drug resistance，pathogen monitoring，and improve the level of empirical drug use.
Key words：Cefoperazone sodium sulbactam sodium；Severe infection；Adverse reactions, 百拇医药(沈孟杰)